SITALICE-M is a combination anti-diabetic medicine used to effectively manage Type 2 Diabetes Mellitus in adults. It contains Sitagliptin, a DPP-4 (Dipeptidyl Peptidase-4) inhibitor, and Metformin, a biguanide. Sitagliptin helps regulate blood sugar levels by increasing insulin release and decreasing glucose production in the liver, especially after meals. Metformin enhances the body’s sensitivity to insulin and helps reduce the absorption of sugar from the intestines. This dual-action approach helps patients achieve better glycemic control, reduce HbA1c levels, and maintain long-term metabolic balance without causing weight gain or frequent episodes of low blood sugar when taken as prescribed.